Understand Viral Clearance During Anion Exchange Chromatography
Demonstrating viral clearance is essential to the downstream processing of certain drugs. However, due to the specialized nature of this quality control step, services are often outsourced contributing to higher workflow costs and slower turnaround times.
Anion exchange chromatography (AEX) is an established downstream processing step in the manufacture of biologics. It’s a good contributor to overall viral clearance and can be optimized to perform well under typical industry conditions.
This webinar explores novel design of experiment (DoE) approaches to improve viral clearance in bioprocessing workflows without the need for costly additional steps.
Watch this webinar to learn more about:
- The value of DoE approaches in bioprocess optimization
- Co-elution mechanisms and the prediction of viral clearance performance
- Achieving the true viral clearance capacity of your downstream processing workflow